MT

Mark A. Tomai

3M: 14 patents #1,097 of 11,543Top 10%
SP Solventum Intellectual Properties: 1 patents #143 of 387Top 40%
Overall (All Time): #313,398 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12099046 Manufacturing a biologic pharmaceutical using causal models Brian E. Brooks, Gilles J. Benoit, Peter O. Olson, Tyler W. Olson, Himanshu Nayar +3 more 2024-09-24
9801947 Methods and compositions for enhancing immune response Richard L. Miller, Ross Kedl, Isidro Zarraga, Ronnie Ortiz, James D. Stoesz +1 more 2017-10-31
8940755 Therapeutic combinations and methods including IRM compounds Gary W. Gullikson, David M. Hammerbeck, Elaine A. Egging, Michael Reiter, Christopher D. Gram +1 more 2015-01-27
7226928 Methods for the treatment of periodontal disease Sumita B. Mitra, Charles E. Shelburne 2007-06-05
6916925 Dye labeled imidazoquinoline compounds Michael J. Rice, Ai-Ping Wei 2005-07-12
6696076 Immune response modifier compounds for treatment of TH2 mediated and related diseases David M. Hammerbeck, Karl F. Swingle 2004-02-24
6630588 Dye labeled imidazoquinoline compounds Michael J. Rice, Ai-Ping Wei 2003-10-07
6610319 Immune response modifier compounds for treatment of TH2 mediated and related diseases David M. Hammerbeck, Karl F. Swingle 2003-08-26
6558951 Maturation of dendritic cells with immune response modifying compounds John Vasilakos, Cory L. Ahonen 2003-05-06
6376669 Dye labeled imidazoquinoline compounds Michael J. Rice, Ai-Ping Wei 2002-04-23
6365166 Gel formulations for topical drug delivery Joseph M. Beaurline, Patrick J. Roddy 2002-04-02
6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases David M. Hammerbeck, Karl F. Swingle 2001-03-13
6083505 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants Richard L. Miller, David I. Bernstein, Christopher J. Harrison 2000-07-04
6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases David M. Hammerbeck, Karl F. Swingle 2000-03-21
5939090 Gel formulations for topical drug delivery Joseph M. Beaurline, Patrick J. Roddy 1999-08-17